.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Chubb
Daiichi Sankyo
Harvard Business School
Moodys
Teva
Dow
Cantor Fitzgerald
US Department of Justice
Fish and Richardson

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072928

« Back to Dashboard
NDA 072928 describes LORAZEPAM, which is a drug marketed by Hospira, Leading Pharma Llc, Lupin Ltd, Watson Labs, Sagent Agila Llc, Akorn, Amneal Pharms, Am Therap, Halsey, Watson Labs Inc, Warner Chilcott, Usl Pharma, Sandoz, Paddock Llc, Sun Pharm Inds Ltd, Superpharm, Roxane, Intl Medication Sys, Frontida Biopharm, Vintage Pharms, Mylan, Pharm Assoc, Hi-tech Pharma Co, Mutual Pharm, Par Pharm, Bedford, Dava Pharms Inc, West-ward Pharms Int, Ani Pharms Inc, and Bedford Labs, and is included in sixty-seven NDAs. It is available from fifty-two suppliers. Additional details are available on the LORAZEPAM profile page.

The generic ingredient in LORAZEPAM is lorazepam. There are eleven drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

Summary for NDA: 072928

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 072928

Ingredient-typeBenzodiazepines

Suppliers and Packaging for NDA: 072928

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LORAZEPAM
lorazepam
TABLET;ORAL 072928 ANDA Actavis Pharma, Inc. 0591-0242 0591-0242-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-0242-01)
LORAZEPAM
lorazepam
TABLET;ORAL 072928 ANDA Actavis Pharma, Inc. 0591-0242 0591-0242-05 500 TABLET in 1 BOTTLE, PLASTIC (0591-0242-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Oct 31, 1991TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Citi
Covington
Teva
Merck
QuintilesIMS
Dow
Mallinckrodt
UBS
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot